PF-3715455 | m-entrepreneurship.com

Product Name :
PF-3715455

Search keywords :
PF-03715455

drugId :
null

Target Vo:
P38 mitogen-activated protein kinase

Target Vo Short Name :
p38 MAPK

Moa_Name:
P38 mitogen-activated protein kinase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Pulmonary Disease, Chronic Obstructive

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PSD95 Antibody
Phospho-eIF4E (Ser209) Antibody
ATG10 Antibody: ATG10 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 25 kDa, targeting to ATG10. It can be used for WB,IHC assays with tag free, in the background of Human and mouse.

Author: Betaine hydrochloride

Related Posts